HSPB1 and ovarian carcinoma: Although the link between HSP27 and cancer cell chemoresistance has been clearly established [11,12,13,19,20], our study demonstrates HSP27 is a novel mediator of COL11A1-driven cisplatin resistance and provides a potential mechanism of how HSP27 becomes upregulated in ovarian cancer.